Cuba vs Tajikistan: HIV-positive TB patients on ART (antiretroviral therapy)
Cuba
100.0%
in 2024
Tajikistan
100.0%
in 2024
Cuba rank
1st
Tajikistan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cuba
- Tajikistan
How they compare
Cuba currently reports 100.0% against 100.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 7 times across 17 shared years of data; in 2007 it was Cuba ahead.
Cuba ranks 1st and Tajikistan ranks 1st of 144 countries.
Cuba has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.7% | 36.0% | 29.7% | Cuba |
| 2010s | 87.3% | 74.2% | 13.1% | Cuba |
| 2020s | 99.0% | 97.8% | 1.2% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cuba or Tajikistan?
- Cuba, at 100.0% against 100.0% in Tajikistan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cuba and Tajikistan?
- 0.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Tajikistan?
- 17 years are reported by both, from 2007 to 2024.
- How do Cuba and Tajikistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cuba ranks 1st and Tajikistan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.